IL313457A - Compressed pyrrolidine psychoplastogens and their uses - Google Patents
Compressed pyrrolidine psychoplastogens and their usesInfo
- Publication number
- IL313457A IL313457A IL313457A IL31345724A IL313457A IL 313457 A IL313457 A IL 313457A IL 313457 A IL313457 A IL 313457A IL 31345724 A IL31345724 A IL 31345724A IL 313457 A IL313457 A IL 313457A
- Authority
- IL
- Israel
- Prior art keywords
- psychoplastogens
- fused pyrrolidine
- pyrrolidine
- fused
- pyrrolidine psychoplastogens
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/14—Ortho-condensed systems
- C07D491/147—Ortho-condensed systems the condensed system containing one ring with oxygen as ring hetero atom and two rings with nitrogen as ring hetero atom
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Addiction (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163290037P | 2021-12-15 | 2021-12-15 | |
| US202263387225P | 2022-12-13 | 2022-12-13 | |
| PCT/US2022/052879 WO2023114320A1 (en) | 2021-12-15 | 2022-12-14 | Fused pyrrolidine psychoplastogens and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL313457A true IL313457A (en) | 2024-08-01 |
Family
ID=86773439
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL313457A IL313457A (en) | 2021-12-15 | 2022-12-14 | Compressed pyrrolidine psychoplastogens and their uses |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP4448532A4 (https=) |
| JP (1) | JP2025502614A (https=) |
| KR (1) | KR20240150418A (https=) |
| AU (1) | AU2022415426A1 (https=) |
| CA (1) | CA3239571A1 (https=) |
| IL (1) | IL313457A (https=) |
| MX (1) | MX2024007220A (https=) |
| TW (1) | TW202333736A (https=) |
| WO (1) | WO2023114320A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2023014630A (es) | 2021-06-08 | 2024-01-30 | Atai Therapeutics Inc | Activadores de dimetoxifenilalquilamina de receptores de serotonina. |
| IL313455A (en) | 2021-12-15 | 2024-08-01 | Delix Therapeutics Inc | Phenoxy and benzyloxy modified psychroplastogens and their uses |
| EP4457203A4 (en) | 2021-12-27 | 2025-12-17 | Atai Therapeutics Inc | AMINOTETRALINE ACTIVATORS OF SEROTONIN RECEPTORS |
| US12343319B2 (en) | 2023-05-01 | 2025-07-01 | Atai Therapeutics, Inc. | Compositions and methods for treatment of diseases and disorders |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK0808312T3 (da) * | 1995-02-02 | 2001-02-12 | Smithkline Beecham Plc | Indolderivater som 5-HT-receptorantagonist |
| AR023574A1 (es) * | 1999-04-23 | 2002-09-04 | Pharmacia & Upjohn Co Llc | Compuestos de azepinindol tetraciclico,composiciones farmaceuticas y el uso de dichos compuestos para preparar un medicamento, e intermediarios |
| WO2002024700A2 (en) * | 2000-09-20 | 2002-03-28 | Pharmacia & Upjohn Company | SUBSTITUTED AZEPINO[4,5b]INDOLINE DERIVATIVES |
| EP1632491A1 (en) * | 2004-08-30 | 2006-03-08 | Laboratorios Del Dr. Esteve, S.A. | Substituted indole compounds and their use as 5-HT6 receptor modulators |
| WO2021076572A1 (en) * | 2019-10-14 | 2021-04-22 | The Regents Of The University Of California | Ergoline-like compounds for promoting neural plasticity |
-
2022
- 2022-12-14 CA CA3239571A patent/CA3239571A1/en active Pending
- 2022-12-14 WO PCT/US2022/052879 patent/WO2023114320A1/en not_active Ceased
- 2022-12-14 JP JP2024533214A patent/JP2025502614A/ja active Pending
- 2022-12-14 MX MX2024007220A patent/MX2024007220A/es unknown
- 2022-12-14 KR KR1020247023489A patent/KR20240150418A/ko active Pending
- 2022-12-14 IL IL313457A patent/IL313457A/en unknown
- 2022-12-14 EP EP22908391.0A patent/EP4448532A4/en active Pending
- 2022-12-14 AU AU2022415426A patent/AU2022415426A1/en active Pending
- 2022-12-14 TW TW111148111A patent/TW202333736A/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TW202333736A (zh) | 2023-09-01 |
| CA3239571A1 (en) | 2023-06-22 |
| WO2023114320A1 (en) | 2023-06-22 |
| EP4448532A1 (en) | 2024-10-23 |
| KR20240150418A (ko) | 2024-10-15 |
| EP4448532A4 (en) | 2025-12-24 |
| AU2022415426A1 (en) | 2024-07-25 |
| JP2025502614A (ja) | 2025-01-28 |
| MX2024007220A (es) | 2024-08-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL313457A (en) | Compressed pyrrolidine psychoplastogens and their uses | |
| IL287391A (en) | Antibody-drug amatoxin as an attached substance and its use | |
| ZA202203580B (en) | Il-17a modulators and uses thereof | |
| HUE064032T2 (hu) | Pozitív elektród-anyag és alkalmazása | |
| SG11202101719PA (en) | Antibody-drug conjugate and application thereof | |
| IL284679A (en) | Multifunctional chimeric proteins and their use | |
| IL289138A (en) | Antibody-drug antibody-tissue mediated conjugates, and related methods | |
| GB202002010D0 (en) | Microtopographies and uses thereof | |
| GB202015226D0 (en) | Pyrrol obenzodiazepine-antibody conugates and uses thereof | |
| IL299254A (en) | Tubulysins and protein-tubulysin conjugates | |
| IL291312A (en) | Anti-ptcra antibody-drug pairings and their use | |
| IL325624A (en) | Clasps and their uses | |
| GB202019767D0 (en) | Compostitions and methods | |
| IL309562A (en) | Regenerative polypeptides and their uses | |
| GB201806022D0 (en) | Pyrrolobenzodiazepines and conjugates thereof | |
| IL309885A (en) | Alpha-surface polypeptides and their use | |
| IL286799A (en) | Consolidated structures and their uses | |
| GB202109082D0 (en) | Polypeptides and uses thereof | |
| GB202111039D0 (en) | Materials and methods | |
| GB201902182D0 (en) | Pyrrolobenzodiazepines and conjugates thereof | |
| EP4423260A4 (en) | Truncated and fusion proteins | |
| HK40117613A (en) | Fused pyrrolidine psychoplastogens and uses thereof | |
| IL311185A (en) | MOG-binding proteins and uses thereof | |
| GB202211784D0 (en) | Methods and uses | |
| GB202106040D0 (en) | Methods and uses |